SS Innovations International (NASDAQ: SSII) is positioning itself as a rising challenger in the global surgical robotics market, leveraging rapid adoption in India and a growing international footprint. The company’s SSi Mantra system, which has now been installed in 224 units across 12 countries, is gaining traction as a cost-effective alternative to established robotic surgery platforms. During the second quarter of 2026, SS Innovations reported a 143% year-over-year increase in robotic procedures, underscoring accelerating utilization among surgeons and hospitals.
The momentum was highlighted by a single-day milestone at Mohak Bariatrics and Robotics in Indore, India, where more than 50 robotic procedures were performed using the SSi Mantra. This level of throughput demonstrates the system’s reliability and efficiency in high-volume clinical settings, a critical factor for broader adoption. Financially, the company’s quarterly revenue climbed 39% to $13.9 million, with system sales up 41% to $12.4 million. Thirty new systems were installed during the quarter, reflecting growing demand.
India remains SS Innovations’ primary commercial market, but the company is actively pursuing regulatory expansion into Europe and the United States. CE marking is targeted for the end of 2026, while FDA review of its 510(k) application is now expected by the end of the first quarter of 2027. These approvals would open access to two of the world’s largest and most lucrative surgical markets, potentially transforming the company’s growth trajectory. The FDA timeline, though slightly delayed, keeps SS Innovations on a path to challenge entrenched competitors like Intuitive Surgical.
Beyond regulatory milestones, SS Innovations is investing in telesurgery capabilities and expanding surgeon training programs. Telesurgery, which allows remote operations, could extend the reach of expert surgeons to underserved regions and create new revenue streams. Training initiatives are essential to drive utilization and ensure safe, effective adoption as the installed base grows. For a deeper look at the company’s progress, see the full article at https://ibn.fm/6FPBS.
The implications of SS Innovations’ expansion are significant for the surgical robotics industry. A lower-cost, clinically proven system could democratize robotic surgery in emerging markets and pressure competitors to adjust pricing strategies. With 224 systems already placed and procedure volumes surging, the company is building the clinical evidence and scale needed to support international expansion. Investors will be watching regulatory decisions in Europe and the U.S., as well as the pace of telesurgery development, as key catalysts.
For ongoing news and updates on SS Innovations, the company’s newsroom is available at https://ibn.fm/SSII. TechMediaWire, a specialized communications platform focused on technology-driven companies, provides coverage of SS Innovations and other emerging players. TechMediaWire operates within the Dynamic Brand Portfolio at IBN, delivering access to wire solutions via InvestorWire and editorial syndication to 5,000+ outlets. The platform also offers press release enhancement and social media distribution to reach millions of followers. For more information, visit TechMediaWire.
